These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7065839

  • 1. Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response.
    van Kammen DP, Docherty JP, Marder SR, Schulz SC, Dalton L, Bunney WE.
    Arch Gen Psychiatry; 1982 Mar; 39(3):261-6. PubMed ID: 7065839
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.
    van Kammen DP, Docherty JP, Bunney WE.
    Biol Psychiatry; 1982 Feb; 17(2):233-42. PubMed ID: 7074181
    [Abstract] [Full Text] [Related]

  • 4. Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients.
    van Kammen DP, Docherty JP, Marder SR, Schulz SC, Bunney WE.
    Arch Gen Psychiatry; 1980 Mar; 37(3):287-90. PubMed ID: 6102456
    [Abstract] [Full Text] [Related]

  • 5. Dextro-amphetamine diminishes negative symptoms in schizophrenia.
    van Kammen DP, Boronow JJ.
    Int Clin Psychopharmacol; 1988 Apr; 3(2):111-21. PubMed ID: 3294284
    [Abstract] [Full Text] [Related]

  • 6. The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol.
    Silverstone T, Cookson J, Ball R, Chin CN, Jacobs D, Lader S, Gould S.
    J Psychiatr Res; 1984 Apr; 18(3):255-68. PubMed ID: 6387105
    [Abstract] [Full Text] [Related]

  • 7. Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent?
    van Kammen DP, Hommer DW, Malas KL.
    Neuropsychobiology; 1987 Apr; 18(3):113-7. PubMed ID: 3453426
    [Abstract] [Full Text] [Related]

  • 8. d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia.
    van Kammen DP, Bunney WE, Docherty JP, Marder SR, Ebert MH, Rosenblatt JE, Rayner JN.
    Am J Psychiatry; 1982 Aug; 139(8):991-7. PubMed ID: 7091448
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
    Feinberg SS, Kay SR, Elijovich LR, Fiszbein A, Opler LA.
    J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia.
    Goldberg TE, Bigelow LB, Weinberger DR, Daniel DG, Kleinman JE.
    Am J Psychiatry; 1991 Jan; 148(1):78-84. PubMed ID: 1984711
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pimozide for schizophrenia or related psychoses.
    Mothi M, Sampson S.
    Cochrane Database Syst Rev; 2013 Nov 05; (11):CD001949. PubMed ID: 24194433
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.